儿童疑似恶性肾肿瘤手术中扩大淋巴结采样不增加术后并发症发生率
该单机构回顾性研究纳入2005至2019年接受肾切除加淋巴结采样的0-18岁疑似恶性肾肿瘤患者144例,中位年龄38个月。21例(15%)发生临床显著并发症,最常见为肠梗阻/小肠梗阻(n=16)。多变量分析显示淋巴结采样数量不影响临床显著并发症的发生 odds(P=0.6)。
要点
- 儿童肾肿瘤手术中扩大淋巴结采样未显著增加临床显著并发症风险。
- 144例中21例(15%)出现临床显著并发症,最常见为肠梗阻/小肠梗阻(n=16)。
- 多变量分析示淋巴结采样数量与临床显著并发症 odds 无关(P=0.6)。
核心结论
- 在该队列中,疑似恶性儿童肾肿瘤手术中更广泛淋巴结采样患者的临床显著并发症无统计学显著差异。
- 作者提出未来应开展关于方案依从性、分期准确性和生存趋势的研究。
研究设计与样本
- 单机构回顾性研究,纳入2005至2019年接受肾切除加淋巴结采样的0-18岁疑似恶性肾肿瘤患者。
- 排除淋巴结采样数为0或未知、或随访<150天的患者,最终144例符合纳入标准,中位年龄38个月。
- 临床显著并发症定义为任何Clavien并发症≥III、小肠梗阻、乳糜腹水、器官损伤或伤口感染。
主要发现
- 144例患者中21例(15%)发生临床显著并发症,最常见为肠梗阻/小肠梗阻(n=16)。
- 多变量分析中,淋巴结采样数量增加未影响发生临床显著并发症的 odds(P=0.6)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Although Children's Oncology Group renal tumor protocols mandate lymph node sampling during extirpative surgery for pediatric renal tumors, lymph node sampling is often omitted or low yield. Concerns over morbidity associated with extended lymph node sampling have led to hesitancy in adopting a formal lymph node sampling template. We hypothesized that complications in children undergoing lymph node sampling for renal tumors would be rare, and not associated with the number of lymph nodes sampled. MATERIALS AND METHODS: A single-institution, retrospective review of patients aged 0-18 years undergoing extirpative renal surgery with lymph node sampling for a suspected malignancy between 2005 and 2019 was performed. Patients with 0 or an unknown number of lymph nodes sampled or <150 days of follow-up were excluded. A "clinically significant" complication was defined as any Clavien complication ≥III, small-bowel obstruction, chylous ascites, organ injury, or wound infection. The number of lymph nodes sampled and its influence on the odds of experiencing a clinically significant complication was examined. RESULTS: A total of 144 patients met inclusion criteria. Median patient age was 38 months. Twenty-one patients (15%) had a clinically significant complication, the most common of which was ileus/small-bowel obstruction (n=16). In a multivariable analysis, increased lymph node yield was not found to influence the odds of experiencing a clinically significant complication (P = .6). CONCLUSIONS: In this cohort, there was no statistically significant difference in clinically significant complications in patients who underwent more extensive lymph node sampling during surgery for a suspected malignant pediatric renal tumor. Future studies on protocol adherence, staging accuracy, and survival trends using a lymph node sampling template in these patients should be performed.
引用
- Walker JP, Han DS, Nicklawsky A, et al. Extended Lymph Node Sampling During Surgery for Pediatric Renal Tumors Concerning for Malignancy Does Not Increase Postoperative Complication Rates. J Urol. 2023. PMID: 36821137. doi:10.1097/JU.0000000000003390
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。